Astromicin
![]() | |
Systematic (IUPAC) name | |
---|---|
2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylacetamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
Legal status |
|
Identifiers | |
CAS Number |
55779-06-1 ![]() |
ATC code | none |
PubChem | CID 65345 |
ChemSpider |
4447577 ![]() |
UNII |
7JHD84H15J ![]() |
KEGG |
D07470 ![]() |
ChEBI |
CHEBI:37923 ![]() |
ChEMBL |
CHEMBL1909053 ![]() |
Chemical data | |
Formula | C17H35N5O6 |
Molar mass | 405.48 g/mol |
| |
| |
![]() ![]() |
Astromicin (INN)(also frequently referenced in scientific journal articles as compounds Fortimicin A/B ) is an aminoglycoside antibiotic. Synthesized from Micromonospora olivasterospora(also named with additional o in olivoasterospora).
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.